SanBio Company Limited

4592

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

NEWUpdated: 2026-09-14FY2027 Q2

Revenue

YoY -

Operating Income

-19.1100M JPY

YoY -1.2%

Net Income

-36.4100M JPY

YoY -1.8%

EPS

-22.9JPY

YoY +17.4%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

-19.7億円

-39.5億円

-59.2億円

-79億円

Rev: -Op: -66.2億円NI: -46.8億円

Rev: -Op: -79億円NI: -55.6億円

Rev: -Op: -45.4億円NI: -26.4億円

Rev: -Op: -35.2億円NI: -28.8億円

Rev: -Op: -37.9億円NI: -38.4億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q2

Net Income34.9%

Revenue Progress-

Revenue Forecast400M

Net Income Progress-17.900M

Net Income Forecast-51.300M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan